In 2024, Bridge To A Cure Foundation turned turbulence into progress. What began as a stormy forecast for childhood cancer research ended with clear signs of brighter days ahead, thanks to a community determined to improve outcomes for kids everywhere.
A Year Defined by Progress
Last year marked critical milestones in Bridge To A Cure’s plan to reduce pediatric brain cancer 50% by 2030.
- Fueled Innovation: We helped advance the M³ scientific approach, integrating multidisciplinary expertise, multiomics data, and multimodal insights to accelerate breakthroughs to cures and cultivate more personalized therapies.
- Expanded Data Access: Our support enabled more than 800 new tissue samples to be processed for the Pediatric Brain Tumor Atlas, now housed in the NIH-funded Kids First Data Resource Center, where it powers discovery alongside 35 other pediatric and rare disease datasets.
- Drove AI-Powered Breakthroughs: Through collaborations like the $10 million ARPA-H RADIANT project, we laid the groundwork for real-time clinical data integration—an innovation that promises to unlock faster, better-informed treatments tailored to each child.
- Catalyzed Safer Therapies: Strategic funding advanced studies in immunotherapy, apoptosis, and angiogenesis—pioneering new ways to fight tumors without devastating side effects.
These aren’t just research terms—they represent real hope for children and families who deserve a future beyond the shadow of cancer.
Robert Martin, Founder and President of Bridge To A Cure Foundation, reflects on this incredible year of progress:
“Our journey began with a promise—one born from love, forged through loss, and carried forward by hope. What started as a vow to one child has become a mission for all: to reduce childhood cancer deaths by 50% by 2030. Together, we are turning storms into sunshine for children everywhere.”
Why It Matters
The truth remains stark: childhood cancer is the leading cause of disease-related death in kids, and most treatments are decades old. But 2024 proved something powerful: collaboration works, data saves lives, and innovation accelerates cures.
The Forecast for 2025: Bold and Clear
Our mission is unwavering: unite and transform the childhood cancer research community to reduce deaths by 50% by 2030. To get there, 2025 is a year of bold initiatives:
- Strengthening Global Data Ecosystems: Invest in platforms that equip researchers across institutions and borders.
- Expanding AI Capabilities: Build AI-powered analytics tools that turn complex data into actionable treatments faster than ever.
- Championing Policy for Progress: Advocate for legislation that sustains research funding and removes barriers to discovery.
- Mobilize the Bridge To A Cure Movement: Engage with families, peer foundations, and industry partners to eliminate silos and amplify impact.
The clouds are breaking, but the work is far from done. Together, we can turn today’s breakthroughs into tomorrow’s cures.
What keeps Bridge To A Cure pushing ahead in 2025? We’re simply Fulfilling the Promise made. You can help us keep our commitment to families facing the devastating effects of brain tumors. Read our 2024 Annual Report. Share our mission. Give to fuel breakthroughs that will save our kids.
